Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ABBOTT LABORATORIES ABT

Healthcare Medical Devices
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the... see more

Recent & Breaking News (NYSE:ABT)

Abbott's FreeStyle Libre® is Named Best Medical Technology in Last 50 Years by the Galien Foundation

PR Newswire October 28, 2022

ABT SHAREHOLDER ALERT: Jakubowitz Law Reminds Abbott Shareholders of a Lead Plaintiff Deadline of October 31, 2022

PR Newswire October 28, 2022

Abbott Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 31, 2022 to Discuss Your Rights - ABT

Newsfile October 27, 2022

ABT LAWSUIT ALERT: Levi & Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire October 27, 2022

ABBOTT LABORATORIES (ABT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Abbott Laboratories (ABT)

Newsfile October 27, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abbott Laboratories - ABT

PR Newswire October 26, 2022

Abbott Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 31, 2022 to Discuss Your Rights - ABT

Newsfile October 26, 2022

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Abbott Laboratories of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 31, 2022 - (NYSE: ABT)

PR Newswire October 26, 2022

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 31, 2022 in Abbott Lawsuit - ABT

Newsfile October 25, 2022

ABT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 31, 2022 in the Class Action Filed on Behalf of Abbott Laboratories Shareholders

PR Newswire October 25, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abbott Laboratories - ABT

Newsfile October 24, 2022

Abbott Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 31, 2022 to Discuss Your Rights - ABT

Newsfile October 24, 2022

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Abbott Investors of a Lead Plaintiff Deadline of October 31, 2022

PR Newswire October 24, 2022

Abbott Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 31, 2022 to Discuss Your Rights - ABT

Newsfile October 23, 2022

ABT APPROACHING DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses Over $100K to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT

PR Newswire October 23, 2022

ABBOTT LABORATORIES SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT

PR Newswire October 21, 2022

Abbott Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 31, 2022 to Discuss Your Rights - ABT

Newsfile October 21, 2022

ABT FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses Over $100K to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT

Newsfile October 21, 2022

ABT SHAREHOLDER ALERT: Jakubowitz Law Reminds Abbott Shareholders of a Lead Plaintiff Deadline of October 31, 2022

PR Newswire October 21, 2022

Abbott Laboratories Deadline Alert

Newsfile October 20, 2022